spironolactone
ApprovedUNKNOWN 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Hypertension
Conditions
Hypertension
Trial Timeline
Sep 1, 2007 โ Dec 1, 2012
NCT ID
NCT00524615About spironolactone
spironolactone is a approved stage product being developed by Richter Gedeon for Hypertension. The current trial status is unknown. This product is registered under clinical trial identifier NCT00524615. Target conditions include Hypertension.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00524615 | Approved | UNKNOWN |
Competing Products
20 competing products in Hypertension